| Revenue growth | Consolidated total income +22% YoY |
|---|---|
| Margins | Consolidated EBITDA margin 26% (+2.8ppt YoY); PAT margin 17% (+6.0ppt) |
| Demand visibility | Iron ore sales +59% YoY; steel volumes +11% YoY |
| Management confidence | Mgmt calls quarter 'healthy' despite slow monsoon |
Growth
Consolidated total income +22% YoY, EBITDA +37%, PAT +88% to ₹261 Cr; H1FY27 PAT +60% to ₹489 Cr.
Outlook
No numeric guidance; ₹220 Cr steel EAF expansion, ₹390 Cr medtech plant (Dec 2027 target), iron ore EC to 9.42 MTPA sought.
Risks
Monsoon-slowed manganese sales (-19% QoQ); 2 of 4 coke batteries idle; forest lease compliance due after Dec 2026.
Investor Presentation filed with NSE, NSE: SANDUMA. Summary written with AI assistance from the document.
Sandur Manganese & Iron Ores Ltd: key numbers
- Share price
- ₹180.94
- Market cap
- ₹8,796 Cr
- Revenue (annual)
- ₹5,088 Cr
- Net profit (annual)
- ₹656.6 Cr
- P/E (TTM)
- 10.5×Sector 17.1×
- Promoter holding
- 74.22%+0.00% QoQ
- FII holding
- 1.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandur Manganese & Iron Ores Ltd
All →Sandur Manganese & Iron Ores Annual General Meeting
Sandur Manganese & Iron Ores issued a postal ballot notice seeking shareholder approval to appoint G. P. Kundargi as Non-Executive Director. Remote e-voting runs from 9 November to 8 December 2026.
Sandur Manganese & Iron Ores Management Change
Sandur Manganese appointed G. P. Kundargi as a Non-Executive Director from 12 November 2026, subject to shareholder approval. He brings mining and metals experience.
Sandur Manganese & Iron Ores Q2 FY27 Results: Net Profit ₹261.2 Cr, Up 88.0% YoY
Sandur Manganese & Iron Ores Ltd reported revenue from operations of ₹1,506 Cr (+22.2% YoY) and net profit of ₹261.2 Cr (+88.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹261.2 Cr · +88.0% YoY
Sandur Manganese & Iron Ores Board Meeting Date
Sandur Manganese & Iron Ores will hold a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the meeting.
Sandur Manganese & Iron Ores Capacity Expansion
SMIORE's subsidiary Royal Sandur MedTech leased 6.2 acres at AP MedTech Zone, Visakhapatnam for a medical devices manufacturing unit. This marks the company's entry into the medical devices segment.
- Execution
- 33-year lease tenure
- land for medical devices manufacturing unit
- 6.2 acres
Sandur Manganese & Iron Ores Other Announcement
Sandur Manganese & Iron Ores Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.